Valuation
- Market cap
- 43,533,000
- Revenue TTM
- $0
- Net income TTM
- $-28,850,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 1,482,500
- Avg volume
- 968,174
- Day's range
- $1.00 – $1.05
- Shares out
- 42,679,000
- Stochastic %K
- 75%
- Beta
- 1.23
- Analysts
- Strong Sell
- Price target
- $10.50
Company profile
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer's disease, as well as in open-label phase 3 to treat parkinson's disease. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and A...
Show more
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer's disease, as well as in open-label phase 3 to treat parkinson's disease. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia. Annovis Bio, Inc. was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 484 875 3192
- Website
- https://www.annovisbio.com
- Address
- 101 Lindenwood Drive, Suite 225, Malvern, United States
Latest news
No headlines yet.
Stocktwits
clearvision
Oct 30, 2:45 AM
$ANVS
im in open label PD trial. over 6 months.
my hands and feet are warm, used to be cold.
Are the autonomic nerves repairing?
1 replies
Always_neutral
Oct 30, 2:33 AM
$ANVS Honest question: are you selling these to unsuspecting poor retail folks? If you are, then I am the poor unsuspecting retail who bought 50 2.5C today at 0.25. You will give me those 1250+commissions back if the drug fails😁😁😁😁. Just kidding, all good. I did buy those though.
0 replies
LPM_ANVS
Oct 30, 12:53 AM
$ANVS In biotech, you don't chase noise; you study the science, secure your entry, and wait like a sniper for the catalyst to strike.
0 replies
NolAsrtormZ
Oct 30, 12:15 AM
$ANVS some entity has hacked crypto site
Happy to be in a Alzheimers data play
0 replies
NolAsrtormZ
Oct 29, 6:28 PM
$ANVS Very bizarre moves today.
Over 1.3 million shares trades +/_ 0.01 range😅
0 replies
NolAsrtormZ
Oct 29, 5:48 PM
$ANVS Last time we had a over 1 million shares traded was October 1st
Dip buyers, Institutional buyers congrats🫣
0 replies
NolAsrtormZ
Oct 29, 5:46 PM
$ANVS seems a bit stronger since all the Jan 2029 call action
0 replies
